Hepatitis B Vaccination Schedule for Infants Born to HBsAg-Positive Mothers
The second dose of hepatitis B vaccine for an infant born to an HBsAg-positive mother should be administered at 1 month of age (option B). 1
Complete Vaccination Schedule for Infants Born to HBsAg-Positive Mothers
The CDC-recommended vaccination schedule for these high-risk infants includes:
- First dose: At birth (within 12 hours of life), along with HBIG at a different injection site 1, 2
- Second dose: At 1-2 months of age 1
- Third dose: At 6 months of age 1
For infants weighing less than 2,000 grams at birth, a 4-dose schedule is recommended:
- Birth
- 1 month
- 2-3 months
- 6 months 1
Important Clinical Considerations
Administration Details
- Only monovalent hepatitis B vaccine should be used for the birth dose 1
- HBIG (0.5 mL) should be administered intramuscularly to the newborn preferably within 12 hours of birth 2
- HBIG efficacy decreases markedly if treatment is delayed beyond 48 hours 2
- The first dose of vaccine may be given concurrently with HBIG but at a separate injection site 2
Follow-up Testing
- Postvaccination serologic testing (PVST) should be performed at age 9-12 months (or 1-2 months after the final vaccine dose if delayed) 1, 3
- Testing should include both HBsAg and anti-HBs levels 1
- Testing should not be performed before 9 months to avoid detection of passive antibodies from HBIG 1
Common Pitfalls to Avoid
Delayed second dose: Research suggests that delaying the second dose beyond 10 weeks increases the risk of chronic HBV infection by 3.74 times in infants born to chronically HBV infected mothers 4
Inadequate follow-up: Ensure completion of the full vaccine series and appropriate serological testing to confirm protection 1
Communication gaps: When infants are transferred between facilities, clear communication about vaccination and HBIG status is essential to prevent errors 1
Low birth weight considerations: Infants with birth weights <2000g have lower seroprotection rates when vaccinated in the first few days of life compared to those vaccinated at 1 month or older (68% vs. 95%) 5
The timely administration of both HBIG and the complete hepatitis B vaccine series is critical for preventing perinatal HBV transmission and the development of chronic hepatitis B infection in these high-risk infants.